XTL Biopharmaceuticals Ltd. reported raising $2.5M in a private placement filing on March 1, 2017
Mar 14, 2017
XTL Biopharmaceuticals Ltd is a biopharmaceutical company, which engages in the acquisition and development of pharmaceutical drugs. Its drug development program focuses on the treatment of systemic lupus erythematosus. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.
In The News
May 15, 2020 - News Bites Canadian Markets
May 01, 2020 - News Bites Canadian Markets
Apr 17, 2020 - News Bites Canadian Markets